Les Sulewski
Stock Analyst at Truist Securities
(1.08)
# 3,864
Out of 5,138 analysts
15
Total ratings
53.85%
Success rate
-14.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $6.98 | +14.61% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $19.16 | +46.14% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $45.60 | +5.26% | 3 | Nov 7, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $25 | $31.76 | -21.28% | 1 | May 28, 2025 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $10 → $12 | $13.41 | -10.51% | 3 | Oct 2, 2024 |
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $6.98
Upside: +14.61%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $19.16
Upside: +46.14%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $45.60
Upside: +5.26%
Teva Pharmaceutical Industries
May 28, 2025
Initiates: Buy
Price Target: $25
Current: $31.76
Upside: -21.28%
Amneal Pharmaceuticals
Oct 2, 2024
Maintains: Buy
Price Target: $10 → $12
Current: $13.41
Upside: -10.51%